134
Participants
Start Date
August 31, 2015
Primary Completion Date
March 31, 2018
Study Completion Date
August 31, 2018
GX-188E
1mg of GX-188E administered IM using EP device at day 0, week 4 and week 12.
Placebo
0.5mL of Placebo administered IM using EP device at day 0, week 4 and week 12.
East Tallinn Central Hospital, Tallinn
North Estonia Medical Centre Foundation, Tallinn
Keimyung University Dongsan Medical Center, Daegu
Inje University Busan Paik Hospital, Busan
Tartu University Hospital, Tartu
Kharkiv medical academy of postgraduate education, Kharkiv
Multi-profile Medical Center (University Clinic No. 1) of Odesa National, Odesa
State Institution Zaporizhzhia Medical Academy of Post-Graduate Education, Zaporizhzhya
Severance Hospital, Seoul
Cheil General Hospital & Women's Healthcare Center, Seoul
CHA Gangnam Medical Center, Seoul
The Catholic University of Korea Seoul St. Mary's Hospital, Seoul
Hallym University Kangnam Sacred Heart Hospital, Seoul
Ehwa Womans University Mokdong Hospital, Seoul
Korea University Guro Hospital, Seoul
National Academy of Medical Sciences of Ukraine, Kyiv
Lead Sponsor
Genexine, Inc.
INDUSTRY